Novel Antidiabetic Therapies and Cardiovascular Risk Reduction: The Role of the Noninferiority Trial.
Article in Cardiology Clinics (May 2019)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk?
Article in International Journal of Cardiology (April 2019)
Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world
Article in BMJ Open Diabetes Research & Care (March 2019)